Abiraterone Acetate contains not less than 98.0% and not more than 102.0% of C26H33NO2, calculated on the as-is basis.

共有 1 個藥物證書使用此成份

阿比特龍乙酸酯
Abiraterone Acetate

• 申請商: 新雙隆生技股份有限公司
• 適應症: 抗腫瘤劑。
• 發證日期: 2023-06-17